Gene · 2272
Papers2,915
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,915
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A review on methods for diagnosis of breast cancer cells and tissues. | Cell Prolif | 2020 | 32530560 | PubTator, text mining | PubMed |
| PHF20L1 as a H3K27me2 reader coordinates with transcriptional repressors to promote breast tumorigenesis. | Sci Adv | 2020 | 32494608 | PubTator, text mining | PubMed |
| Relationship between Methylation of FHIT and CDH13 Gene Promoter Region and Liver Cancer. | Curr Med Sci | 2020 | 32474857 | PubTator, text mining | PubMed |
| LKB1 mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trial. | ESMO Open | 2020 | 32467099 | PubTator, text mining | PubMed |
| Biological Difference Between Epstein-Barr Virus Positive and Negative Post-transplant Lymphoproliferative Disorders and Their Clinical Impact. | Front Oncol | 2020 | 32457824 | PubTator, text mining | PubMed |
| Genome Maintenance by DNA Helicase B. | Genes (Basel) | 2020 | 32455610 | PubTator, text mining | PubMed |
| Genomic integrity of human induced pluripotent stem cells across nine studies in the NHLBI NextGen program. | Stem Cell Res | 2020 | 32442913 | PubTator, text mining | PubMed |
| An Integrated Approach for Preventing Oral Cavity and Oropharyngeal Cancers: Two Etiologies with Distinct and Shared Mechanisms of Carcinogenesis. | Cancer Prev Res (Phila) | 2020 | 32434808 | PubTator, text mining | PubMed |
| Amplification of 3q26.2, 5q14.3, 8q24.3, 8q22.3, and 14q32.33 Are Possible Common Genetic Alterations in Oral Cancer Patients. | Front Oncol | 2020 | 32426287 | PubTator, text mining | PubMed |
| Immunotherapy as a treatment for small cell lung cancer: a case report and brief review. | Transl Lung Cancer Res | 2020 | 32420081 | PubTator, text mining | PubMed |
| Comparative toxicity analysis of corannulene and benzo[a]pyrene in mice. | Toxicol Lett | 2020 | 32417428 | PubTator, text mining | PubMed |
| Genome-Wide Profiling of Human Papillomavirus DNA Integration into Human Genome and Its Influence on PD-L1 Expression in Chinese Uygur Cervical Cancer Women. | J Immunol Res | 2020 | 32411801 | PubTator, text mining | PubMed |
| Role of Molecular Chaperones in Carcinogenesis: Mechanism, Diagnosis, and Treatment. | J Oncol | 2020 | 32377195 | PubTator, text mining | PubMed |
| Genome-Wide Analysis of the DNA Methylation Profile Identifies the Fragile Histidine Triad (FHIT) Gene as a New Promising Biomarker of Crohn's Disease. | J Clin Med | 2020 | 32375395 | PubTator, text mining | PubMed |
| Role of HSP60/HSP10 in Lung Cancer: Simple Biomarkers or Leading Actors? | J Oncol | 2020 | 32318107 | PubTator, text mining | PubMed |
| Shallow whole-genome sequencing of plasma cell-free DNA accurately differentiates small from non-small cell lung carcinoma. | Genome Med | 2020 | 32317009 | PubTator, text mining | PubMed |
| Mammalian RAD51 paralogs protect nascent DNA at stalled forks and mediate replication restart. | Nucleic Acids Res | 2020 | 32301983 | PubTator, text mining | PubMed |
| A reference map of the human binary protein interactome. | Nature | 2020 | 32296183 | PubTator, text mining | PubMed |
| NT157 has antineoplastic effects and inhibits IRS1/2 and STAT3/5 in JAK2V617F-positive myeloproliferative neoplasm cells. | Signal Transduct Target Ther | 2020 | 32296029 | PubTator, text mining | PubMed |
| Nrf1 Is Endowed with a Dominant Tumor-Repressing Effect onto the Wnt/β-Catenin-Dependent and Wnt/β-Catenin-Independent Signaling Networks in the Human Liver Cancer. | Oxid Med Cell Longev | 2020 | 32273945 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2272/papers?page=32